Jump Financial, LLC Cara Therapeutics, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Oct 21, 2024	BUY	$2.83 - $4.94 $63,958 - $111,644	22,600 New	22,600 $63,000
Q2 2023 Aug 07, 2023	BUY	$2.83 - $4.94 $63,958 - $111,644	22,600 New	22,600 $63,000
Q3 2022 Nov 07, 2022	SELL	$8.24 - $12.56 $68,268 - $104,059	-8,285 Reduced 19.05%	35,200 $329,000
Q2 2022 Aug 09, 2022	SELL	$7.45 - $13.84 $90,115 - $167,408	-12,096 Reduced 21.76%	43,485 $397,000
Q1 2022 May 12, 2022	BUY	$9.94 - $12.65 $552,475 - $703,099	55,581 New	55,581 $675,000
Q4 2021 Feb 10, 2022	SELL	$11.99 - $18.14 $515,294 - $779,602	-42,977 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $496,384 - $690,210	42,977 New	42,977 $664,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.